318 related articles for article (PubMed ID: 26475669)
1. Cancer in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era.
Brickman C; Palefsky JM
Curr HIV/AIDS Rep; 2015 Dec; 12(4):388-96. PubMed ID: 26475669
[TBL] [Abstract][Full Text] [Related]
2. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
[TBL] [Abstract][Full Text] [Related]
3. Evolving epidemiology of malignancies in HIV.
Bonnet F; Chêne G
Curr Opin Oncol; 2008 Sep; 20(5):534-40. PubMed ID: 19106656
[TBL] [Abstract][Full Text] [Related]
4. The Role of Cancer Biomarkers in HIV Infected Hosts.
Galati D; Zanotta S
Curr Med Chem; 2016; 23(22):2333-49. PubMed ID: 27237819
[TBL] [Abstract][Full Text] [Related]
5. Managing Pharmacotherapy in People Living With HIV and Concomitant Malignancy.
Olin JL; Klibanov O; Chan A; Spooner LM
Ann Pharmacother; 2019 Aug; 53(8):812-832. PubMed ID: 30770025
[No Abstract] [Full Text] [Related]
6. [HIV-related malignancies: state of art].
Gobert A; Mounier N; Lavole A; Poizot-Martin I; Spano JP
Bull Cancer; 2014 Nov; 101(11):1020-9. PubMed ID: 25418594
[TBL] [Abstract][Full Text] [Related]
7. Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era.
Bedimo R
Curr HIV/AIDS Rep; 2008 Aug; 5(3):140-9. PubMed ID: 18627663
[TBL] [Abstract][Full Text] [Related]
8. Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?
Silverberg MJ; Abrams DI
Curr Opin HIV AIDS; 2009 Jan; 4(1):42-51. PubMed ID: 19339938
[TBL] [Abstract][Full Text] [Related]
9. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
Barbaro G; Barbarini G
Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
[TBL] [Abstract][Full Text] [Related]
10. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002.
Bedimo R; Chen RY; Accortt NA; Raper JL; Linn C; Allison JJ; Dubay J; Saag MS; Hoesley CJ
Clin Infect Dis; 2004 Nov; 39(9):1380-4. PubMed ID: 15494916
[TBL] [Abstract][Full Text] [Related]
11. Retrospective cohort study of cancer incidence and mortality by HIV status in a Georgia, USA, prisoner cohort during the HAART era.
Zlotorzynska M; Spaulding AC; Messina LC; Coker D; Ward K; Easley K; Baillargeon J; Mink PJ; Simard EP
BMJ Open; 2016 Apr; 6(4):e009778. PubMed ID: 27067888
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
13. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.
Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
Int J Cancer; 2015 Nov; 137(10):2443-53. PubMed ID: 25976897
[TBL] [Abstract][Full Text] [Related]
14. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy.
Galli L; Spagnuolo V; Poli A; Salpietro S; Gianotti N; Cossarini F; Carbone A; Nozza S; Bossolasco S; Bigoloni A; Lazzarin A; Castagna A
AIDS; 2014 Oct; 28(16):2407-15. PubMed ID: 25160933
[TBL] [Abstract][Full Text] [Related]
15. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
[TBL] [Abstract][Full Text] [Related]
16. [Consensus statement on the clinical management of non-AIDS defining malignancies. GeSIDA expert panel].
Santos J; Valencia E;
Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):515-22. PubMed ID: 24953385
[TBL] [Abstract][Full Text] [Related]
17. The Pattern of Non-AIDS-defining Cancers in the HIV Population: Epidemiology, Risk Factors and Prognosis. A Review.
Franzetti M; Ricci E; Bonfanti P
Curr HIV Res; 2019; 17(1):1-12. PubMed ID: 30919779
[TBL] [Abstract][Full Text] [Related]
18. Lung Cancer in HIV-Infected Patients.
Mena Á; Meijide H; Marcos PJ
AIDS Rev; 2016; 18(3):138-144. PubMed ID: 27438573
[TBL] [Abstract][Full Text] [Related]
19. Impact of early recognition of potentially malignant oral disorders on the prognosis in people living with HIV.
Anaya-Saavedra G; Ramírez-Amador V; Castillejos-García I; Saeb-Lima M
Int J STD AIDS; 2019 Jun; 30(7):723-726. PubMed ID: 31046610
[TBL] [Abstract][Full Text] [Related]
20. The growing problem of non-AIDS-defining malignancies in HIV.
Pantanowitz L; Schlecht HP; Dezube BJ
Curr Opin Oncol; 2006 Sep; 18(5):469-78. PubMed ID: 16894295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]